Tenon Medical, Inc. (TNON)

Market Cap	4.82M
Revenue (ttm)	2.40M
Net Income (ttm)	-20.35M
Shares Out	2.47M
EPS (ttm)	-16.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,175
Open	1.87
Previous Close	1.88
Day's Range	1.82 - 1.97
52-Week Range	0.77 - 27.40
Beta	n/a
Analysts	Strong Buy
Price Target	60.00 (+2,976.92%)
Earnings Date	Nov 14, 2023

About TNON

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquar...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 27, 2022
• Employees: 22
• Stock Exchange: NASDAQ
• Ticker Symbol: TNON

Financial Performance

In 2022, Tenon Medical's revenue was $691,000, an increase of 331.87% compared to the previous year's $160,000. Losses were -$18.92 million, 168.4% more than in 2021.

Analyst Forecast

According to one analyst, the rating for TNON stock is "Strong Buy" and the 12-month stock price forecast is $60.0.

Price Target

$60.0

(2,976.92% upside)

Analyst Consensus: Strong Buy